Alexion makes $930M acquisition in bid to bolster blockbuster drug – Boston Business Journal

1000x-1

Written by Allison DeAngelis

One of the Boston area’s biotech giants is spending close to $1 billion to acquire a Pennsylvania startup developing a companion to its cornerstone product.

Alexion (Nasdaq: ALXN) announced Wednesday that it will acquire clinical-stage startup Achillion Pharmaceuticals Inc. (Nasdaq: …

By Alessandra Leone
Alessandra Leone Profile Picture
Read more »

Flagship Pioneering Unveils Cygnal Therapeutics – Flagship Pioneering

download (1)

CAMBRIDGE, Mass., Oct. 8, 2019 /PRNewswire/ — Flagship Pioneering, a unique life sciences innovation enterprise, today unveiled Cygnal Therapeutics. Founded in 2017 in Flagship Labs, Flagship’s innovation foundry, Cygnal is the first company to develop drugs in the field of …

By Molly Raddant
Molly Raddant Profile Picture
Read more »

Scientists designed a drug for just 1 patient. Her name is Mila. – Boston.com

DNA Strands on blue background , 3d render

Written by Gina Kolata.

A new drug, created to treat just one patient, has pushed the bounds of personalized medicine and has raised unexplored regulatory and ethical questions, scientists reported Wednesday.

The drug, described in the New England Journal of …

By Molly Raddant
Molly Raddant Profile Picture
Read more »

CRISPR gene editing startup Beam Therapeutics plans $100M IPO – Boston Business Journal

beam therapeutics

Written by Allison DeAngelis

Mere months after raising $135 million from investors, another gene editing startup co-founded by MIT researcher Feng Zhang is preparing to go public.

Cambridge’s Beam Therapeutics filed documents with the SEC after markets closed Friday disclosing …

By Jessica Yap-Chung
Jessica Yap-Chung Profile Picture
Read more »

European biotech firm BioNtech plans to raise nearly $304 million in U.S. IPO – Reuters

1

Written by Ralph Orlowski

BioNtech SE, Europe’s largest unlisted biotech firm by staff numbers, said on Tuesday that it planned to raise up to $303.6 million in an initial public offering in the United States.

The company expects its offering …

By sophiata@bu.edu
sophiata@bu.edu Profile Picture
Read more »